Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Get the Prostate.net RSS feed

Tag Archives: Hormone Therapy

New Prostate Cancer Drug Alpharadin Improves Survival

It’s not often that the monitoring committee during a Phase III trial ends the study early because the drug has performed so well, but that’s what happened with the new prostate cancer drug, Alpharadin. The investigators report that men with metastatic, hormone-resistant prostate cancer lived a median of three months longer when taking Alpharadin.


More about: , ,

Hormone Therapy and Celecoxib in Prostate Cancer

The addition of the COX-2 inhibitor celecoxib (Celebrex) to hormone therapy may cause regression of tumor growth in advanced prostate cancer. Scientists at the Vaccine Research Institute of San Diego used a mouse model of prostate cancer to evaluate the efficacy of this combination approach. Hormone therapy (also known as androgen ablation therapy) in prostate… Continue Reading »


More about: , ,

Prostate Cancer Hormone Treatments May Raise Risk of Colorectal Cancer

A large, retrospective population study suggests that prostate cancer treatments that lower male sex hormones may increase the risk of colorectal cancer. Men treated with gonadotropin-releasing hormone (GnRH) agonists or surgical removal of their testicles (orchiectomy) to lower their testosterone and PSA levels experienced an increased risk of colorectal cancer of about 20 to 40… Continue Reading »


More about: , ,

  • ADVERTISEMENT


  • ADVERTISEMENT